B Group, Inc. - 18 Aug 2025 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Reporting relationship: 10%+ Owner
Issuer ticker: NRXP
Reported as of: 18 Aug 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 21 Aug 2025, 06:21:37 UTC
Source filing: View source filing
Reporting owner signature: /s/ Branden B. Muhl, Chief Executive Officer

Key filing fact

B Group, Inc. filed Form 3 for NRX Pharmaceuticals, Inc. (NRXP) on 21 Aug 2025.

Key facts

This page summarizes B Group, Inc.'s Form 3 filing for NRX Pharmaceuticals, Inc. (NRXP).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 21 Aug 2025, 06:21.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002043476 Primary reporting owner

B Group, Inc.

Relationship: 10%+ Owner
Address: 2900 MCKINNON STREET, SUITE 1101, DALLAS
Signature: /s/ Branden B. Muhl, Chief Executive Officer
Signature date: 20 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NRXP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,000,000
Date: 18 Aug 2025
Ownership: See Note 1
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting persons are The B Group, Inc. ("B Group"), B Group Capital LLC (the "Fund") and Branden B. Muhl. B Group is the investment adviser of the Fund. Mr. Muhl is the manager and controlling owner of the Fund and B Group, respectively. B Group is filing this Form 3 for itself, the Fund and Mr. Muhl. The securities are held directly by the Fund. The reporting persons are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 3d-5(b) under the Securities Exchange Act of 1934, as amended. B Group may be deemed to indirectly beneficially own the securities as the investment adviser to the Fund. Mr. Muhl may be deemed to indirectly beneficially own securities as the manager of the Fund and control person of B Group. The reporting persons disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.